Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10 |
filingDate |
2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d94c361b8cceffa7ff1a6aef8f156d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b688127d941930cb099f7317df02ce8c |
publicationDate |
2007-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1869046-A1 |
titleOfInvention |
Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
abstract |
The invention provides compounds of general formula. [Chemical formula should be inserted here. Please see paper copy] (II) wherein R and R1 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy. |
priorityDate |
2005-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |